Latent is making significant strides in the healthcare sector by leveraging clinical AI to redefine how medication access is managed. Founded in 2022, this innovative company is collaborating with leading health systems to enhance processes like prior authorizations, 340B compliance, and appeals.
Their slogan, "Building the clinical reasoning engine to close the gap between diagnosis and treatment," succinctly encapsulates their mission. By optimizing pharmacy workflows and promoting centralization, Latent aims to accelerate the time-to-therapy for patients, facilitate scalable pharmacy expansion, and lessen administrative burdens.
Headquartered in the United States, the company operates within the Health Care, Insurance, and SaaS industries. In April 2023, Latent secured a $500.00K Pre Seed Round investment from Y Combinator, underscoring investor confidence in their innovative approach and growth potential. This infusion of capital is set to accelerate Latent's expansion and impact across the healthcare landscape.